Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 3
2009 2
2010 4
2011 7
2012 4
2013 8
2014 13
2015 6
2016 8
2017 3
2018 3
2019 1
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
Model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients.
Yoshioka H, Sato H, Hatakeyama H, Hisaka A. Yoshioka H, et al. Among authors: hatakeyama h. Blood Adv. 2018 May 22;2(10):1066-1075. doi: 10.1182/bloodadvances.2017013805. Blood Adv. 2018. PMID: 29760204 Free PMC article.
Advances in an active and passive targeting to tumor and adipose tissues.
Sakurai Y, Kajimoto K, Hatakeyama H, Harashima H. Sakurai Y, et al. Among authors: hatakeyama h. Expert Opin Drug Deliv. 2015 Jan;12(1):41-52. doi: 10.1517/17425247.2015.955847. Epub 2014 Nov 7. Expert Opin Drug Deliv. 2015. PMID: 25376864 Review.
Multifunctional Envelope-Type Nano Device: Evolution from Nonselective to Active Targeting System.
Hayashi Y, Hatakeyama H, Kajimoto K, Hyodo M, Akita H, Harashima H. Hayashi Y, et al. Among authors: hatakeyama h. Bioconjug Chem. 2015 Jul 15;26(7):1266-76. doi: 10.1021/acs.bioconjchem.5b00184. Epub 2015 Jun 5. Bioconjug Chem. 2015. PMID: 25938819 Review.
Investigation of Metabolomic Changes in Sunitinib-Resistant Human Renal Carcinoma 786-O Cells by Capillary Electrophoresis-Time of Flight Mass Spectrometry.
Hatakeyama H, Fujiwara T, Sato H, Terui A, Hisaka A. Hatakeyama H, et al. Biol Pharm Bull. 2018;41(4):619-627. doi: 10.1248/bpb.b17-00992. Biol Pharm Bull. 2018. PMID: 29607935 Free article.
Trichostatin A modulates cellular metabolism in renal cell carcinoma to enhance sunitinib sensitivity.
Sato H, Uzu M, Kashiba T, Fujiwara T, Hatakeyama H, Ueno K, Hisaka A. Sato H, et al. Among authors: hatakeyama h. Eur J Pharmacol. 2019 Mar 15;847:143-157. doi: 10.1016/j.ejphar.2019.01.040. Epub 2019 Jan 26. Eur J Pharmacol. 2019. PMID: 30689992
[Development of an efficient short interference RNA (siRNA) delivery system with a new pH-sensitive cationic lipid].
Sato Y, Hatakeyama H, Hyodo M, Akita H, Harashima H. Sato Y, et al. Among authors: hatakeyama h. Yakugaku Zasshi. 2012;132(12):1355-63. doi: 10.1248/yakushi.12-00234-2. Yakugaku Zasshi. 2012. PMID: 23208041 Free article. Review. Japanese.
Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer.
Huang Y, Lichtenberger LM, Taylor M, Bottsford-Miller JN, Haemmerle M, Wagner MJ, Lyons Y, Pradeep S, Hu W, Previs RA, Hansen JM, Fang D, Dorniak PL, Filant J, Dial EJ, Shen F, Hatakeyama H, Sood AK. Huang Y, et al. Among authors: hatakeyama h. Mol Cancer Ther. 2016 Dec;15(12):2894-2904. doi: 10.1158/1535-7163.MCT-16-0074. Epub 2016 Sep 16. Mol Cancer Ther. 2016. PMID: 27638860 Free PMC article.
60 results
Jump to page